ProGen Search

Intelligence

Commissioned Intelligence

Commissioned intelligence for leadership teams, boards and investors. You bring the decision; we scope the evidence that answers it and deliver it under NDA. Built from the same market knowledge that runs our searches, so it names real organisations and real people where the work calls for it.

A decision in front of you?

Tell us what you need to know.

Request intelligence

Confidential. We reply with a scope and a fixed proposal.

Commission

Evidence for the decision in front of you

Grow revenue

Market Maps & Go-to-Market

Every company in the segment you want to sell into, the people who sign inside them, and a plan to reach them.

See what is included →

Price and shape the team

Compensation & Organisation Benchmarks

What your roles cost, how they should be levelled, and how your organisation compares with the companies you compete with.

See what is included →

Protect the plan

Leadership Team Diligence

An evidence-based read on whether a leadership team can deliver the plan it is being asked to deliver.

See what is included →

An intelligence partner on call

Ongoing Intelligence

Written briefs on the bids, competitors, partners and customers in front of you, each turned round in five working days, every month.

  • Up to four written briefs a month on a named bid, competitor, partner or customer
  • Each brief turned round in five working days from an agreed scope
  • Bid briefs: who else is in the frame, indicative pricing and lead times where supportable, what wins and the pitfalls
  • Facts linked to their sources, with our own reading clearly labelled
  • For teams who need the whole market in view: a private platform with your market kept up to date for everyone who needs it

Billed monthly after a short initial term. Larger questions, such as a full market study, are scoped and agreed separately before any work starts.

Discuss ongoing coverage

Intelligence

Recent work

Radiopharma

Compensation and levelling framework for a US radiopharmaceutical site

challenge
A radiopharmaceutical manufacturer scaling a US production site needed pay bands it could defend and a role ladder that held together across six functions, at a time when experienced radiopharma operators were being bid up across the market.
work
Role-by-role compensation benchmarks across six functions and the full ladder, role levelling, and the package structures comparable companies use to hire and retain.
outcome
One framework covering every role in scope, built for setting offers and running pay reviews from the same evidence.

Radiopharma

Organisation benchmark for a GMP radiopharmaceutical site

challenge
The same client needed to know whether its GMP site was sized and structured like comparable radioligand therapy companies, function by function, before committing to the next phase of hiring.
work
Headcount and structure benchmarked across quality, quality control, sterility assurance, production, MS&T, facilities and radiation protection, plus group clinical, pre-clinical and supply chain.
outcome
A function-by-function view of where the site was in line with its peers, where it was thin and where it was ahead.

Market entry

US market entry for a European life-science equipment manufacturer

challenge
A European manufacturer with a strong home market and little US presence needed to know who to sell to in the US, who signs inside those accounts, and how to reach them.
work
Every target account in the segment mapped and segmented, named decision-makers account by account, a working target dashboard, and the outreach plan.
outcome
A US business development programme built for the client's own team to run from its dashboard, in place of a cold start.

Working together

How engagements work

  1. 01

    Scoping call

    Agree the decision, the evidence needed and the boundaries of the work.

  2. 02

    Written proposal with a fixed fee

    Scope, deliverables and timing set out before you commit.

  3. 03

    Delivery under NDA

    Confidential evidence and a discussion of what it means for your decision.

Methodology

How Our Intelligence Is Built

Our market intelligence is built from live executive search mandate data, operator-level conversations, and regulatory analysis. We synthesise what we learn from running retained searches across radiopharma, CDMO, CRO, ADC and cell and gene therapy, combined with deep research into sector structure, competitive dynamics, and workforce economics. This is not reformatted publicly available information.

Published intelligence

Market Analysis →Intelligence Vault →ProGen Radar →

Send us the question

Tell us the decision you are facing and the evidence you need. We will come back to you to agree the scope.